BioAffinity Technologies Inc (NASDAQ:BIAF) currently has a daily average trading volume of 9.53M but it saw 464504 shares traded in last market. With a market cap of 9.40M USD, the company’s current market price of $0.51 came rising about 9.67 while comparing to the previous closing price of $0.47. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.16 and as low as $0.24. In the recent trading on the day, stock has struck highest price mark of $0.488 while lowest mark touched by it was $0.58.
Taking a look at 20-day trading activity of BioAffinity Technologies Inc (BIAF) gives us an average price of $0.5143, while its current price level is -83.72% below from 52-week high level whereas it is 114.23% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5418 while that of 200 days or SMA-200 reads an average of $1.2823. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.41% during that period while stretching the period over a month that increases to 26.02%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 49.38 which implies that the stock is in neutral territory.
Over the week, BIAF’s stock price is moving -8.05% down while it is 79.76% when we observe its performance for the past one month. Year-to-date it is -43.41% down and over the past year, the stock is showing a downside performance of -81.80%.
The company is expected to be releasing its next quarterly report on 2025-Mar-30, for which analysts forecasted an EPS of -0.16 while estimate for next year EPS is -0.45. In next quarter, company is expected to be making quarterly sales of $1.21M as analysts are expecting the sales for current fiscal year at $6.05M and seeing the company making $7.25M in sales next year. Moreover, analysts are in estimates of $2.11M for current-quarter revenue.
Currently, BioAffinity Technologies Inc’s total number of outstanding shares is 15.58M. Company’s return on investment (ROI) stands at -265.19% and return on equity (ROE) at -242.44%. Stock’s beta reads 1.94. Stock has a price to book (P/B) ratio of 3.08 while price to sale or P/S ratio amounts to 1.00. Its return on asset (ROA) is -122.70% on average.
